Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine.

Holmes A, Quirk GJ.

Trends Pharmacol Sci. 2010 Jan;31(1):2-7. doi: 10.1016/j.tips.2009.10.003. Epub 2009 Dec 28. Review.

2.

Yohimbine impairs extinction of cocaine-conditioned place preference in an alpha2-adrenergic receptor independent process.

Davis AR, Shields AD, Brigman JL, Norcross M, McElligott ZA, Holmes A, Winder DG.

Learn Mem. 2008 Aug 26;15(9):667-76. doi: 10.1101/lm.1079308. Print 2008 Sep.

3.

The effects of yohimbine and amphetamine on fear expression and extinction in rats.

Mueller D, Olivera-Figueroa LA, Pine DS, Quirk GJ.

Psychopharmacology (Berl). 2009 Jul;204(4):599-606. doi: 10.1007/s00213-009-1491-x. Epub 2009 Feb 26.

4.

The effect of yohimbine on the extinction of conditioned fear: a role for context.

Morris RW, Bouton ME.

Behav Neurosci. 2007 Jun;121(3):501-14.

PMID:
17592941
5.

Learning not to fear, faster.

Quirk GJ.

Learn Mem. 2004 Mar-Apr;11(2):125-6. No abstract available.

PMID:
15054126
6.

Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.

Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG.

Neuropsychopharmacology. 2012 Sep;37(10):2253-66. doi: 10.1038/npp.2012.76. Epub 2012 May 23. Erratum in: Neuropsychopharmacology. 2013 May;38(6):1140.

7.

The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.

Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y.

Neuropsychopharmacology. 2006 Oct;31(10):2188-96. Epub 2005 Dec 7.

8.

Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.

Holmes A, Yang RJ, Crawley JN.

J Mol Neurosci. 2002 Feb-Apr;18(1-2):151-65.

PMID:
11931346
9.

Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.

Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY.

World J Gastroenterol. 2008 Apr 21;14(15):2358-63.

10.

Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats.

Park CR, Campbell AM, Diamond DM.

Biol Psychiatry. 2001 Dec 15;50(12):994-1004.

PMID:
11750896
11.

Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain.

Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A.

J Neurosci. 2008 Aug 6;28(32):8074-85. doi: 10.1523/JNEUROSCI.4904-07.2008.

12.

Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning.

Nasehi M, Zamanparvar M, Ebrahimi-Ghiri M, Zarrindast MR.

Behav Brain Res. 2016 Mar 1;300:114-22. doi: 10.1016/j.bbr.2015.12.017. Epub 2015 Dec 14.

PMID:
26698395
14.
15.

Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.

Powers MB, Smits JA, Otto MW, Sanders C, Emmelkamp PM.

J Anxiety Disord. 2009 Apr;23(3):350-6. doi: 10.1016/j.janxdis.2009.01.001. Epub 2009 Jan 15.

PMID:
19223151
16.

Impairment of contextual conditioned fear extinction after microinjection of alpha-1-adrenergic blocker prazosin into the medial prefrontal cortex.

Do-Monte FH, Allensworth M, Carobrez AP.

Behav Brain Res. 2010 Jul 29;211(1):89-95. doi: 10.1016/j.bbr.2010.03.014. Epub 2010 Mar 19.

PMID:
20227443
17.

Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment.

Rabinak CA, Phan KL.

Curr Pharm Des. 2014;20(13):2212-7. Review.

PMID:
23829364
18.

Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear.

Graham BM, Richardson R.

Neuropsychopharmacology. 2010 May;35(6):1348-55. doi: 10.1038/npp.2010.3. Epub 2010 Feb 3.

19.

The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues.

Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA.

Neuropsychopharmacology. 2008 May;33(6):1402-12. Epub 2007 Jul 25.

20.

The use of cognitive enhancers in animal models of fear extinction.

Kaplan GB, Moore KA.

Pharmacol Biochem Behav. 2011 Aug;99(2):217-28. doi: 10.1016/j.pbb.2011.01.009. Epub 2011 Jan 20. Review.

PMID:
21256147

Supplemental Content

Support Center